Design and Optimization of a Nanoparticulate Pore Former as a Multifunctional Coating Excipient for pH Transition-Independent Controlled Release of Weakly Basic Drugs for Oral Drug Delivery
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Design and Optimization of a Nanoparticulate Pore Former as a Multifunctional Coating Excipient for pH Transition-Independent Controlled Release of Weakly Basic Drugs for Oral Drug Delivery. / Chang, Hao Han R.; Chen, Kuan; Lugtu-Pe, Jamie Anne; AL-Mousawi, Nour; Zhang, Xuning; Bar-Shalom, Daniel; Kane, Anil; Wu, Xiao Yu.
In: Pharmaceutics, Vol. 15, No. 2, 547, 2023.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Design and Optimization of a Nanoparticulate Pore Former as a Multifunctional Coating Excipient for pH Transition-Independent Controlled Release of Weakly Basic Drugs for Oral Drug Delivery
AU - Chang, Hao Han R.
AU - Chen, Kuan
AU - Lugtu-Pe, Jamie Anne
AU - AL-Mousawi, Nour
AU - Zhang, Xuning
AU - Bar-Shalom, Daniel
AU - Kane, Anil
AU - Wu, Xiao Yu
N1 - Funding Information: This project is supported in part by the Natural Sciences and Engineering Research Council (NSERC) Discovery grant (RGPIN-2019-07204) and equipment grants (EQPEQ 374799-09, EQPEQ 440689-13) to X.W.; and the Mitacs Accelerate Internship to H.H.R.C. with Patheon by Thermo Fisher Scientific (IT08610). Funding Information: The authors would like to thank BASF, Colorcon, and Croda for providing samples of PVP, Surelease EC, and PS 80, respectively; and to thank David Dubins, for the use of the fluid bed coater in the Patheon Pharmaceutics Teaching Laboratory; and to thank the Departmental Scholarships and Hoffman-La Roche/Rosemarie Hager Graduate Fellowship to K.C., and to thank the Dean’s Fund for Ph.D. Scholarship to J.A.L.-P.; and to thank the stipendium from the government of Denmark to N.A.-M. ®
PY - 2023
Y1 - 2023
N2 - Bioavailability of weakly basic drugs may be disrupted by dramatic pH changes or unexpected pH alterations in the gastrointestinal tract. Conventional organic acids or enteric coating polymers cannot address this problem adequately because they leach out or dissolve prematurely, especially during controlled release applications. Thus, a non-leachable, multifunctional terpolymer nanoparticle (TPN) made of cross-linked poly(methacrylic acid) (PMAA)-polysorbate 80-grafted-starch (PMAA-PS 80-g-St) was proposed to provide pH transition-independent release of a weakly basic drug, verapamil HCl (VER), by a rationally designed bilayer-coated controlled release bead formulation. The pH-responsive PMAA and cross-linker content in the TPN was first optimized to achieve the largest possible increase in medium uptake alongside the smallest decrease in drug release rate at pH 6.8, relative to pH 1.2. Such TPNs maintained an acidic microenvironmental pH (pHm) when loaded in ethylcellulose (EC) films, as measured using pH-indicating dyes. Further studies of formulations revealed that with the 1:2 VER:TPN ratio and 19% coating weight gain, bilayer-coated beads maintained a constant release rate over the pH transition and exhibited extended release up to 18 h. These results demonstrated that the multifunctional TPN as a pHm modifier and pH-dependent pore former could overcome the severe pH-dependent solubility of weakly basic drugs.
AB - Bioavailability of weakly basic drugs may be disrupted by dramatic pH changes or unexpected pH alterations in the gastrointestinal tract. Conventional organic acids or enteric coating polymers cannot address this problem adequately because they leach out or dissolve prematurely, especially during controlled release applications. Thus, a non-leachable, multifunctional terpolymer nanoparticle (TPN) made of cross-linked poly(methacrylic acid) (PMAA)-polysorbate 80-grafted-starch (PMAA-PS 80-g-St) was proposed to provide pH transition-independent release of a weakly basic drug, verapamil HCl (VER), by a rationally designed bilayer-coated controlled release bead formulation. The pH-responsive PMAA and cross-linker content in the TPN was first optimized to achieve the largest possible increase in medium uptake alongside the smallest decrease in drug release rate at pH 6.8, relative to pH 1.2. Such TPNs maintained an acidic microenvironmental pH (pHm) when loaded in ethylcellulose (EC) films, as measured using pH-indicating dyes. Further studies of formulations revealed that with the 1:2 VER:TPN ratio and 19% coating weight gain, bilayer-coated beads maintained a constant release rate over the pH transition and exhibited extended release up to 18 h. These results demonstrated that the multifunctional TPN as a pHm modifier and pH-dependent pore former could overcome the severe pH-dependent solubility of weakly basic drugs.
KW - bilayer-coated beads
KW - controlled release
KW - microenvironmental pH modifier
KW - multifunctional terpolymer excipient
KW - nanogel optimization
KW - pH-independent release
KW - pH-responsive nanoparticles
KW - pore former
KW - weakly basic drug
U2 - 10.3390/pharmaceutics15020547
DO - 10.3390/pharmaceutics15020547
M3 - Journal article
C2 - 36839869
AN - SCOPUS:85149144256
VL - 15
JO - Pharmaceutics
JF - Pharmaceutics
SN - 1999-4923
IS - 2
M1 - 547
ER -
ID: 339334341